Author: yourbiotech

The anti-inflammatory treatment is for Duchenne muscular dystrophy Santhera has announced that the company has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for vamorolone. The therapy is used for the treatment of Duchenne muscular dystrophy (DMD). At the core of the MAA submission is positive data from the pivotal phase 2b Vision-DMD study that comprised a 24-week period to demonstrate efficacy and safety of the drug versus prednisone (0.75mg/kg/day) and placebo. This was followed by a 24-week period to evaluate the maintenance of efficacy and collect additional longer-term safety and tolerability data. In addition, the…

Read More

Rosen Law Firm, a global investor rights law firm, reminds sellers of the stock of Sinovac Biotech Ltd. (NASDAQ: SVA) between April 11, 2016 and February 22, 2019, both dates inclusive (the “Class Period”), of the October 17, 2022 lead plaintiff deadline in the lawsuit against 1Globe Capital LLC and certain of its officers. SO WHAT: If you sold Sinovac securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Sinovac class action, go to https://rosenlegal.com/submit-form/?case_id=8179 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the…

Read More

President Joe Biden is launching a new initiative to encourage biotech production and research in the U.S., the latest move by the White House to boost domestic industry. Biden on Monday signed an executive order implementing the initiative and later, in remarks at the John F. Kennedy Presidential Library in Boston, will address how biotech can help fight cancer. On Wednesday, the Democratic president’s administration will host a summit and announce new investments from several federal agencies, according to a White House fact sheet. The initiative will seek to boost biomanufacturing in pharmaceuticals but also in other industries such as…

Read More

University of Lincoln and the University of Sheffield are researching how DNA could be repaired New research has found that there is a link between non-coding DNA and certain neurological disorders such as Alzheimer’s and motor neurone disease. A team from the University of Lincoln and the University of Sheffield identified how oxidative breaks in so-called ‘junk’ DNA are formed and repaired, exploring how the repairing of these breaks could protect us from neurological diseases in the future. The discovery unlocks the potential for pioneering new research into this ‘junk’ DNA, which makes up 98% of our total cellular DNA.…

Read More

Indian equity benchmarks BSE Sensex and NSE Nifty50 are likely to make a gap-down opening on Friday ahead of the outcome of a three-day meeting of the RBI’s rate-setting panel. Singapore Exchange (SGX) Nifty futures — an early indicator of the Nifty index — fell as much as 34.5 points or 0.21 percent to 16,777.5 ahead of the opening on D-Street. CNBC-TV18’s in-house panel of experts has picked a list of stocks for investors to buy/sell in trade today: Mitessh Thakkar of earningwaves.com Buy IRCTC for a target of Rs 740 with a stop loss at Rs 690 Buy Havells for a target of Rs…

Read More

Researchers have identified a mechanism by which an oncogene commonly activated in cancer patients affects the growth rate of cells. In the future, the findings can help in developing new treatments that could prevent cancer genes from inducing tumor growth. Researchers focusing on the effects of the MYC oncogene have revealed new information about the factors that regulate the growth of cancer cells. MYC promotes the expression of genes that are important for cellular growth, and it is known to be overactive in more than half of all human cancers. However, there are no drugs currently available for inhibiting MYC…

Read More

Torrent Pharma | The shares of Torrent Pharmaceuticals Ltd jumped 3.3 percent on September 29 after the US Food and Drug Administration issued a ‘Form 483’ with 3 observations for the company’s manufacturing facility at Indrad, Gujarat. The company has, however, clarified that none of these observations were related to data integrity.  Its stock ended 3.6 percent higher. Asian Paints Ltd | Nifty50’s top loser, its stock ended 4.7 percent down. The Ramco Cements Ltd | Shares of Ramco Cements Ltd rose as much as 2.2 percent on Thursday, a day after the company said it had commissioned a fifth integrated cement plant with…

Read More

Over the past few years, the pandemic fueled a massive boom in biotech investing. Funding for biotech companies soared in 2021 to nearly $47 billion — a record for the industry. This year has marked a slowdown. As the global economy becomes more uncertain, venture capitalists have become cautious about investing in startups of all kinds — including biotech firms. Some private biotechs are delaying going public, and even preparing to raise down rounds. Despite the market downturn, some companies are still raising sizable funding rounds. One key to these is a great pitch deck, the presentation that companies use to solicit funding from investors.…

Read More

Torrent Pharma (TRP) is set to acquire Curatio Healthcare (Curatio) for enterprise value of INR19b. While the acquisition will help with the company’s portfolio expansion and widen its reach to dermatologists/paediatricians, the deal valuation is expensive at 6.8x EV/ FY23 sales, 22.4x EV/FY23 EBITDA basis. We reduce our EPS estimate by 2% for FY24 to factor in the Curatio acquisition. We value TRP at 26x 12M forward earnings to arrive at a price target of INR1500. Considering its limited upside potential, we reiterate our Neutral stance on the stock. We have tweaked our EPS estimate by -2% for FY24 to…

Read More

A clinical intervention, which involved the administration of an injection of a commonly used local anaesthetic agent, costing as low as Rs 100 has been developed by doctors at the Tata Memorial Centre (TMC) to increase breast cancer cure and survival rates, the hospital said on Monday. The study by a team from TMC, a premiere cancer institute under the Centre’s Department of Atomic Energy, over a decade led to the development of the intervention with higher efficacy. “The research has .. The study was conducted by investigators at 11 cancer centres in India including Tata Memorial Centre in Mumbai over…

Read More